Trump, Middle East and Oil
Digest more
Top News
Overview
Impacts
Trump, AMD and NVIDIA
Digest more
Top News
Overview
Reactions and opinions
China, Trump and Trade Deal
Digest more
Trump’s partial tariff pause could suggests a floor on how low equities can go before triggering a policy pivot. But investors should beware.
On two occasions now, Trump has gotten in front of major trade announcements and urged investors to buy stocks.
1don MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.
1don MSN
For a few tense days last month, it looked like a roaring bull market for U.S. stocks was coming to an end after an impressive 2½ year run.
Drugmakers' shares fell globally after President Trump said he would [sign an executive order](
Rep. Jared Moskowitz bought tens of thousands of dollars in stock in 20 different companies just two days before Trump announced a tariff pause.
Shares of pharmaceutical companies were under pressure ahead of Monday’s open after President Donald Trump said he will sign an executive order to slash prescription-drug prices. In a post on his Truth Social platform on Sunday,
By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges.
Markets cheer tariff reprieve, Republican budget proposal includes funding cuts to Medicaid, Tesla worth $1 trillion, more news to start your day.